We are live on ! Find out more
CCM

Channing Capital Management Portfolio holdings

AUM $4.34B
1-Year Est. Return 37.08%
This Fund
S&P 500
This Quarter Est. Return
-3.83%
1 Year Est. Return
+37.08%
3 Year Est. Return
+81.15%
5 Year Est. Return
+102.23%
10 Year Est. Return
+435.32%
AUM
$3.64B
AUM Growth
-$82.8M
Cap. Flow
+$94.2M
Cap. Flow %
2.58%
Top 10 Hldgs %
23.95%
Holding
114
New
7
Increased
53
Reduced
45
Closed
8

Top Sells

Rank Stock Value
1
VSTS icon
Vestis
VSTS
+$68.8M
2
ONB icon
Old National Bancorp
ONB
+$62.5M
3
MEDP icon
Medpace
MEDP
+$44.8M
4
LPX icon
Louisiana-Pacific
LPX
+$22.6M
5
ITGR icon
Integer Holdings
ITGR
+$11M

Sector Composition

Rank Sector Weight
1 Industrials 23.99%
2 Financials 20.99%
3 Technology 14.13%
4 Healthcare 8.65%
5 Consumer Discretionary 8.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CR icon
76
Crane Co
CR
$12.7B
$8.61M 0.24%
+59,405
New +$8.42M
LAD icon
77
Lithia Motors
LAD
$8.26B
$8.6M 0.24%
34,061
+3,671
+12% +$961K
WFC icon
78
Wells Fargo
WFC
$264B
$8.54M 0.23%
143,800
-25,402
-15% -$1.5M
JNJ icon
79
Johnson & Johnson
JNJ
$625B
$8.52M 0.23%
58,321
+5,291
+10% +$787K
SRE icon
80
Sempra
SRE
$54.8B
$8.29M 0.23%
108,953
-1,953
-2% -$144K
FAF icon
81
First American
FAF
$7.58B
$8.18M 0.22%
151,659
-1,075
-0.7% -$59.7K
MDLZ icon
82
Mondelez International
MDLZ
$79.9B
$8.03M 0.22%
122,700
+18,208
+17% +$1.25M
EOG icon
83
EOG Resources
EOG
$70.7B
$7.89M 0.22%
62,667
+14,621
+30% +$1.88M
ELAN icon
84
Elanco Animal Health
ELAN
$11.1B
$7.6M 0.21%
526,501
+27,235
+5% +$435K
BDX icon
85
Becton Dickinson
BDX
$48.7B
$7.49M 0.21%
32,045
-466
-1% -$110K
EPAM icon
86
EPAM Systems
EPAM
$5.09B
$7.24M 0.2%
+38,510
New +$8.21M
IBM icon
87
IBM
IBM
$224B
$7.22M 0.2%
41,732
+19,754
+90% +$3.43M
GMED icon
88
Globus Medical
GMED
$11.2B
$7.21M 0.2%
105,253
-35,994
-25% -$2.15M
CB icon
89
Chubb
CB
$135B
$7.19M 0.2%
28,191
-2,306
-8% -$592K
ETR icon
90
Entergy
ETR
$50B
$7.19M 0.2%
134,326
-2,412
-2% -$130K
CNC icon
91
Centene
CNC
$32.5B
$7.08M 0.19%
106,771
+8,810
+9% +$641K
GS icon
92
Goldman Sachs
GS
$303B
$6.93M 0.19%
15,323
-2,605
-15% -$1.14M
MDT icon
93
Medtronic
MDT
$112B
$6.76M 0.19%
85,844
+12,494
+17% +$1.02M
BA icon
94
Boeing
BA
$185B
$6.67M 0.18%
36,662
-6,109
-14% -$1.09M
NOC icon
95
Northrop Grumman
NOC
$81.2B
$6.66M 0.18%
15,275
+1,460
+11% +$667K
CZR icon
96
Caesars Entertainment
CZR
$6.14B
$6.53M 0.18%
164,391
-77,067
-32% -$2.9M
ULTA icon
97
Ulta Beauty
ULTA
$24.3B
$6.48M 0.18%
16,804
-2,358
-12% -$958K
FTAI icon
98
FTAI Aviation
FTAI
$22.2B
$6.43M 0.18%
62,301
-24,635
-28% -$1.96M
CME icon
99
CME Group
CME
$94.8B
$6.25M 0.17%
31,780
-2,545
-7% -$526K
AMD icon
100
Advanced Micro Devices
AMD
$789B
$6.23M 0.17%
+38,399
New +$6.18M

Similar funds

Channing Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Channing Capital Management held 114 positions worth $3.64B, down 2.2% from $3.73B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Channing Capital Management's Q2 2024 filing shows 7 new, 53 increased, 45 reduced and 8 closed positions. Its largest new stake was Veeco: 395,891 shares worth $18.5M. The largest sale was Vestis, an estimated $68.8M.

By sector, the portfolio is most concentrated in Industrials at 24% of assets, down from 27% a quarter earlier, followed by Financials and Technology.

  • Channing Capital Management's largest Q2 2024 buy was Veeco: 395,891 shares worth $18.5M.
  • Channing Capital Management added most to Littelfuse in Q2 2024, an estimated $77.3M increase.
  • Channing Capital Management's biggest Q2 2024 reduction was Louisiana-Pacific, cutting an estimated $22.6M.
  • Channing Capital Management fully exited Vestis in Q2 2024, selling an estimated $68.8M.
  • Channing Capital Management's ten largest holdings make up 24% of its $3.64B portfolio in Q2 2024.
  • Channing Capital Management opened 7 new positions and closed 8 in Q2 2024.
  • Channing Capital Management's portfolio value fell 2.2% quarter-over-quarter to $3.64B.

Based on Channing Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.